Details of the Drug
General Information of Drug (ID: DMI7LF1)
| Drug Name | 
                     JWH-302 
                 | 
            ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | 
                                         
                        JWH-302; UNII-DQF20NHW2M; DQF20NHW2M; CHEMBL186674; 2-(3-Methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone; 864445-45-4; JWH 302; SCHEMBL2471302; DTXSID60467554; XZVYWLVYUAQEIM-UHFFFAOYSA-N; ZINC28456868; BDBM50170333; CCG-208748; 1-pentyl-3-(3-methoxyphenylacetyl)indole; FT-0670596; 2-(3-Methoxy-phenyl)-1-(1-pentyl-1H-indol-3-yl)-ethanone; Ethanone, 2-(3-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)-
                        
                     
                                     | 
            ||||||||||||||||||||||
| Indication | 
                                                            
  | 
            ||||||||||||||||||||||
| Drug Type | 
                     Small molecular drug 
                 | 
            ||||||||||||||||||||||
| Structure | 
                    ![]()  | 
            ||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 335.4 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 5 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 8 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
| Chemical Identifiers | 
                        
  | 
                ||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT)  | 
                
                    
  | 
            ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
                    
  | 
            ||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||


